Summary of Classification and Labelling
Notified classification and labelling
General Information
827-334-7 |
4-[(4-CHLOROPHENYL)METHYL]-2-[[(2R)-1-[4-[4-[3-(HEXAHYDRO-1H-AZEPIN-1-YL)PROPOXY]PHENYL]BUTYL]-2-PYRROLIDINYL]METHYL]-1(2H)-PHTHALAZINONE, DIHYDROCHLORIDE |
955359-75-8 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(liver)
(oral)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(Liver)
(oral)
|
H373
|
Number of Aggregated Notifications: 1